Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models

Peptides

Volumn 20, Issue 9, 1999, Pages 1071-1077

  Xu, Mei ^a   Kontinen, Vesa K ^a   Panula, Pertti ^b   Kalso, Eija ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Carrageenan inflammation; Neuropathic pain; Neuropeptide FF analog; Nociception; Spinal

Indexed keywords

MORPHINE; NALOXONE; NEUROPEPTIDE; NEUROPEPTIDE FF; NEUROPEPTIDE FF DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPERALGESIA; INTRATHECAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL NERVE; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

EID: 0032871754     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00100-X     Document Type: Article

References (45)

1. Allard M.P., Vincent J.D., Simonnet G., Geoffe S. Characterization of rat spinal cord receptors Legendreto FLFQPQRFamide, a mammalian morphine modulating peptide a binding study . Brain Res. 500:1989;169-176.
2. Allard M., Theodosis D.T., Rousselot P., Lombard M.C., Simonnet G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord biochemical and immunocytochemical studies . Neuroscience. 40:1991;81-92.
3. Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 59:1994;369-376.
4. ére Réunion de la Société Francaise de Pharmacologie (Marseilles, France) 1997;17:23.
5. Courteix C., Coudoré M.A., Eschalier A., Fialip J., Zajac J.M., Lavarenne J. CI988, an antagonist of cholecystokinin type B receptor and 1DMe, an analogue of neuropeptide FF, enhance the analgesic effect of morphine in diabetic rats. Proc Suppl Br J Pharmacol. 122:1997;335.
6. Desprat C., Zajac J.M. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Brain Res Dev Brain Res. 82:1994;118-126.
7. Devillers J.P., Mazarguil H., Allard M., Dickenson A.H., Zajac J.M., Simonnet G. Characterization of a potent agonist for NPFF receptors binding study on rat spinal cord membranes . Neuropharmacology. 33:1994;661-669.
8. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15:1992;96-103.
9. Dupouy V., Zajac J.M. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul Pept. 59:1995;349-356.
10. Ericson E., Samuelsson J., Ahlenius S. Photocell measurements of rat motor activity. J Pharmacol Methods. 25:1991;111-122.
11. Gicquel S., Fioramonti J., Bueno L., Zajac J.M. Effects of F8Famide analogs on intestinal transit in mice. Peptides. 14:1993;749-753.
12. Gicquel S., Mazaraguil H., Allard M., Simonnet G., Zajac J-M. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur J Pharmacol. 222:1992;61-67.
13. Gouarderes C., Jhamandas K., Sutak M., Zajac J.M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br J Pharmacology. 117:1996;493-501.
14. Gouarderes C., Sutak M., Zajac J.M., Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol. 237:1993;73-81.
15. 125I][D-Tyr1, (NMe)Phe3]NPFF. Brain Res Bull. 42:1997;231-238.
16. Gouarderes C., Tafani J.A., Zajac J.M. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord. Peptides. 19:1998;727-730.
17. Greenberg M.J., Painter S.D., Doble K.E., Nagle G.T., Price D.A., Lehman H.K. The molluscan neurosecretory peptide FMRFamide comparative pharmacology and relationship to the enkephalins . Federation Proceedings. 42:1983;82-86.
18. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
19. Hirata H., Pataky A., Kajander K., LaMotte R.H., Collins J.G. A model of peripheral mononeuropathy in the rat. Pain. 42:1990;253-254.
20. Hylden J.K., Thomas D.A., Iadarola M.J., Nahin R.L., Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia possible involvement of noradrenergic mechanisms . Eur J Pharmacol. 194:1991;135-143.
21. Joris J., Costello A., Dubner R., Hargreaves K.M. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain. 43:1990;95-103.
22. Kavaliers M. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia on mice. Neuro Sci Lett. 115:1990;307-312.
23. Kavaliers M., Yang H-YT. Effects of mammalian FMRF-NH2-related peptides and IgG from antiserum against them on aggression and defeat-induced analgesia in mice. Peptides. 12:1991;235-239.
24. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
25. Kivipelto L., Rubenstein J., Yang H.-Y.T., Panula P. Ontogeny of the F8Famide-like (morphine-modulating) peptides in the central nervous system of rats. J Comp Neurol. 304:1991;14-33.
26. Kontinen V.K., Aarnisalo A.A., Idänpään-Heikkilä J.J., Panula P., Kalso E. Neuropeptide FF in the rat spinal cord during carrageenan inflammation. Peptides. 18:1997;287-292.
27. Kontinen V.K., Kalso E.A. Differential modulation of α2-adrenergic and μ-opioid spinal antinociception by neuropeptide FF. Peptides. 16:1995;973-977.
28. Kontinen V.K., Paananen S., Kalso E. Systemic morphine in the prevention of allodynia in the rat spinal nerve ligation model of neuropathic pain. Eur J Pain. 2:1998;35-42.
29. Lake J.R., Hebert K.M., Payza K., Deshotel K.D., Hausam D.D., Witherspoon W.E., Arcangeli K.A., Malin D.H. Analog of neuropeptide FF attenuates morphine tolerance. Neurosci Lett. 146:1992;203-206.
30. Malin D.H., Lake J.R., Hammond M.V., Fowler D.E., Rogillo R.B., Brown S.L., Sims J.L., Leecraft B.M., Yang H-YT. FMRF-NH2-like mammalian octapeptide possible role in opiate dependence and abstinence . Peptides. 11:1990;969-972.
31. Malin D.H., Lake R., Leyva J.E., Hammond M.V., Rogillio R.B., Arcangeli A.R., Ludgate K., Moore G.M., Payza K. Analog of neuropeptide FF attenuates morphine abstinence syndrome. Peptides. 12:1991;1011-1014.
32. Million M., Fioramonti J., Gicquel S., Zajac J.M., Bueno L. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats. J Pharmacol Exp Ther. 265:1993;96-102.
33. Panula P., Aarnisalo A.A., Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions [published erratum appears in Prog Neurobiol 1996;49:285]. Prog Neurobiol. 48:1996;461-487.
34. Ren K., Dubner R. NMDA receptor antagonists attenuate mechanical hyperalgesia in rat with unilateral inflammation of the hindpaw. Neurosci Lett. 163:1993;22-26.
35. Rothman R.B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 12:1992;129-138.
36. Stanfa L., Dickenson A., Xu X.-J., Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia variations on a theme . Trends Pharmacol Sci. 15:1994;65-66.
37. Stanfa L.C., Sullivan A.F., Dickenson A.H. Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation. Pain. 50:1992;345-354.
38. 2-like immunoreactivity. Proc Natl Acad Sci USA. 81:1984;5002-5005.
39. Verge V.M., Wiesenfeld H.Z., Hokfelt T. Cholecystokinin in mammalian primary sensory neurons and spinal cord in situ hybridization studies in rat and monkey . Eur J Neurosci. 5:1993;240-250.
40. Vilim FS, Aarnisalo AA, Nieminen ML, Lintunen M, Karlstedt K, Kontinen VK, Kalso E, States B, Panula P, Ziff E. Gene for pain modulatory peptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol (in press).
41. Winter C.A., Risley E.A., Nuss G.W. Carrageenin induced oedema in the hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med. 111:1962;544-547.
42. Yaksh T.L., Pogrel J.W., Lee Y.W., Chaplan S.R. Reversal of nerve ligation-induced allodynia by spinal α-2 adrenoceptor agonists. J Pharmacol Exp Ther. 272:1995;207-214.
43. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17:1976;1031-1036.
44. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA. 82:1985;7757-7761.
45. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain. 16:1983;109-110.